PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Dianthin-30 is similar to saporin-S3 and S6, which are used to design targeted toxins for tumor therapy; dianthin may be more suitable for targeted tumor therapies than other RIPs due to differences in structure, efficacy, toxicity, and immunogenicity [PMID:31614697]
Methanol extracts from carnation flowers and roots exhibit superior antioxidant and anti-tumor capabilities compared to stems and leaves [PMID:39239204]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33200329 (2020) — Cryopreservation of carnation (Dianthus caryophyllus L.) and other Dianthus species. · Planta
- 2.PMID: 37600187 (2023) — A chromosome-scale and haplotype-resolved genome assembly of carnation (Dianthus caryophyllus) based on high-fidelity sequencing. · Frontiers in plant science
- 3.PMID: 31614697 (2019) — Dianthin and Its Potential in Targeted Tumor Therapies. · Toxins
- 4.PMID: 10400858 (1999) — Occupational allergy caused by carnation (Dianthus caryophyllus). · The Journal of allergy and clinical immunology
- 5.PMID: 26236320 (2015) — Identification of heat-responsive genes in carnation (Dianthus caryophyllus L.) by RNA-seq.